Ergothioneine and the Blue Zones: A Dietary Connection?

Ergothioneine, Longevity, and Age-Related Decline

1,344 adults

In Japan's Hisayama Study, higher serum ergothioneine was significantly associated with lower dementia risk over 11.2 years of follow-up, evidence that traditional high-mushroom diets may deliver longevity benefits through this specific compound.

Meng et al., Psychiatry Clin Neurosci, 2025

11.2 yrs

median follow-up in the Hisayama cohort, the longest longitudinal ergothioneine study in humans

1.1 mg

estimated daily ergothioneine in U.S. diets vs. higher intakes in Asian mushroom-eating populations

fungi only

ergothioneine is produced almost exclusively by fungi, making mushrooms its sole dietary source

Meng et al., Psychiatry Clin Neurosci, 2025

View as image ↗

Researchers studying the five Blue Zones (regions where people consistently live longer than average) have catalogued their diets for decades. The usual conclusions focus on legumes, vegetables, moderate fish, low meat, and social connection. Mushrooms appear in the dietary data for some regions, especially Okinawa, but rarely receive specific attention. A growing body of research suggests that oversight may matter. Ergothioneine, a compound produced almost exclusively by fungi and found at the highest levels in mushrooms, has emerged as a candidate for one of the most testable dietary explanations for why high-mushroom populations live longer.

The evidence is not a closed case. A 2025 Japanese cohort study tracking 1,344 older adults for 11.2 years found that higher serum ergothioneine significantly reduced risk of dementia and Alzheimer's disease.^[1] A 2020 review found that Americans consume an estimated 1.1 mg of ergothioneine per day, far below the levels found in populations with traditional mushroom-heavy diets.^[2] Taken together, these data points sketch a hypothesis: Blue Zone populations that eat substantial amounts of mushrooms may benefit partly from ergothioneine, a compound their Western counterparts barely consume.

This article traces that three-part argument with primary citations. It also states the caveat plainly: Blue Zone longevity is multifactorial, ergothioneine is one proposed mechanism among many, and the connection is a hypothesis, not established fact.

For background on what ergothioneine is and why the body has a dedicated cellular transporter for it, see Ergothioneine: The Amino Acid Your Body Hoards. For the broader longevity vitamin hypothesis across the full research arc, see Ergothioneine: The Longevity Vitamin Hypothesis.

What Blue Zone Diets Actually Have in Common: More Mushrooms Than Anyone Tracked

The five original Blue Zones identified by researcher Dan Buettner are Okinawa (Japan), Sardinia (Italy), Nicoya (Costa Rica), Icaria (Greece), and Loma Linda (California). Each has been analyzed for dietary patterns. The shared dietary features that receive the most attention are high legume intake, low meat consumption, predominantly plant-based eating, and moderate caloric restriction.

Mushrooms appear in the dietary data for several of these regions, most prominently Okinawa. Traditional Okinawan cuisine features shiitake, enoki, maitake, and wood ear mushrooms as regular daily ingredients, not occasional additions. Sardinian mountain diets also include local wild mushrooms seasonally. Icarian cuisine incorporates foraged fungi.

What's notable is how rarely mushrooms are foregrounded in Blue Zone dietary analyses. They appear in food lists but don't receive the kind of specific attention that legumes or fish get. Ergothioneine research offers one reason to revisit that omission: because ergothioneine is produced almost exclusively by fungi, mushroom-eating populations have access to a compound that doesn't meaningfully exist in other food groups.

The argument is not that mushrooms are the secret of the Blue Zones. It's more specific: among the many dietary factors that vary between high-longevity and low-longevity populations, ergothioneine is unusually testable because its dietary source is so narrow. High mushroom intake means high ergothioneine intake. And ergothioneine levels in blood can now be measured in large population studies.

Why Mushrooms Are the Only Meaningful Source: The Fungi-Exclusive Story

Ergothioneine is biosynthesized almost exclusively by fungi, including the mycorrhizal fungi that colonize plant roots. Animals and humans cannot make it. No other major food group provides amounts that come close to mushrooms.^[3]

This exclusivity has two implications for the Blue Zones story. First, populations whose diets include regular mushroom consumption are the populations with meaningful ergothioneine intake. Second, the compound cannot be obtained through dietary substitution. You cannot eat more vegetables or fruit to compensate for low mushroom consumption. The only path to higher ergothioneine is through fungi or supplementation.

Cheah and Halliwell's 2021 comprehensive review, one of the most cited papers on ergothioneine biology, notes that the compound accumulates in specific human tissues through a dedicated transporter (OCTN1), concentrating especially in mitochondria-rich cells, red blood cells, and neurons.^[3] The transporter's existence is considered evidence that ergothioneine serves a specific physiological function, not simply that the body passively absorbs whatever arrives in food.

For the specific argument for why fungi are the only producers, see Why Only Fungi Make Ergothioneine (And Why That Matters).

The American Diet's Ergothioneine Deficit: 1.1 mg/Day vs. What the Data Suggests

Beelman and colleagues assembled the most comprehensive estimate of U.S. dietary ergothioneine intake in their 2020 review and arrived at approximately 1.1 mg/day for the average American adult.^[2]

This number is useful not because we know the "correct" intake for health, but because it provides a baseline for comparison. Countries with traditional high mushroom consumption have substantially higher average intakes. Japan, South Korea, Italy, and parts of Northern Europe all consume more mushrooms per capita than the United States. The difference between 1.1 mg/day in the U.S. and the higher intakes in mushroom-heavy dietary cultures is the ergothioneine gap that researchers argue may have health consequences over decades.

Beelman's review also synthesized epidemiological data showing that higher ergothioneine intake is associated with lower total mortality and lower neurological disease mortality, drawing on multiple population studies.^[2] The review stops short of causal claims but establishes that the association is consistent across data sources.

The Blue Zones interpretation builds on this: if populations with high ergothioneine intake live longer, and if Blue Zone populations like Okinawa have traditionally high ergothioneine intake through mushrooms, then ergothioneine may be one of the dietary mediators of their longevity advantage. That's the hypothesis. Every key word in it requires qualification: "may," "one of," "hypothesis." But it is testable in ways that broader dietary pattern claims are not.

Japan's Hisayama Study: A Natural Experiment in a High-Mushroom Population

The most powerful evidence relevant to the Blue Zones-ergothioneine connection comes from a study that wasn't designed to test the Blue Zones hypothesis at all. The Hisayama Study, conducted in Hisayama town in Fukuoka, Japan, has been running longitudinal aging research since 1961 and is one of the world's most rigorous community-based epidemiological cohorts.

In 2025, Meng and colleagues published Hisayama Study findings specifically examining serum ergothioneine and dementia risk.^[1] The study followed 1,344 community-dwelling Japanese adults aged 65 and older for a median of 11.2 years. At baseline, serum ergothioneine was measured. Outcomes tracked over the follow-up period included all-cause dementia, Alzheimer's disease, and non-Alzheimer's dementia.

Higher serum ergothioneine at baseline was significantly associated with reduced risk across all three outcome categories. The findings held after adjustment for age, sex, cardiovascular risk factors, and baseline cognitive status.

What makes this finding so directly relevant to the Blue Zones argument is the population. Japan has traditional high mushroom consumption. A Japanese cohort aged 65 and older in 2025 grew up eating mushrooms as dietary staples. The variation in ergothioneine levels within that cohort reflects real-world dietary differences between people who ate more or fewer mushrooms throughout their lives. The study is not comparing Japan to the U.S. It is showing that within a high-mushroom population, the people who happened to have higher ergothioneine had substantially lower dementia risk over more than a decade of follow-up.

This is the closest thing available to a long-term test of what higher ergothioneine intake, accumulated over a lifetime of mushroom-heavy diet, does to cognitive aging outcomes. For what the research shows about what happens as ergothioneine levels fall with age, see Ergothioneine Declines with Age: What This Means for Health.

The Swedish Cohort: European Mushroom Eaters Show the Same Pattern

The Hisayama Study is not the only high-follow-up human data. Smith and colleagues published findings from a Swedish prospective cohort in 2020, with a median follow-up of 21.4 years, and found that higher plasma ergothioneine was significantly associated with lower coronary disease risk, lower cardiovascular mortality, and lower all-cause mortality.^[4]

Sweden is not a Blue Zone. But Sweden has substantially higher mushroom consumption than the United States, including traditional foraging cultures that incorporate porcini, chanterelle, and other wild species into cooking. The Swedish population in this cohort had more natural dietary variation in ergothioneine than a U.S. cohort would.

The fact that ergothioneine-longevity associations appear in a Swedish cohort (cardiovascular outcomes, 21.4 years) and a Japanese cohort (dementia outcomes, 11.2 years) from independent research groups in different countries strengthens the case that the association is not a statistical artifact of one population's specific confounders.

For a deeper look at the mortality data across these population studies, see Blood Ergothioneine Levels and All-Cause Mortality Risk.

What NHANES Shows: U.S. Mushroom Eaters Live Longer Too

Two independent analyses of U.S. National Health and Nutrition Examination Survey (NHANES) data found that mushroom consumption predicts lower mortality in American adults, even in a population with low baseline ergothioneine intake.

Ba and colleagues found that mushroom consumers in NHANES III had significantly lower all-cause mortality risk compared to non-consumers, after adjusting for diet quality, income, activity level, smoking, and other standard confounders.^[5] A separate prospective analysis of NHANES 2003-2014 data, combined with a meta-analysis to pool independent studies, confirmed the same inverse association.^[6]

The Ba 2021 papers are significant for the Blue Zones hypothesis for a specific reason. The U.S. mushroom-eating population is still getting far less ergothioneine than traditional Okinawan or Swedish diets. Yet even at those modest dietary increments, the mortality signal appears. This suggests that the dose-response relationship is not limited to high-intake populations. Small increases in dietary ergothioneine intake, achievable by eating mushrooms occasionally rather than as a daily staple, appear to shift health outcomes measurably.

For more on this dietary evidence specifically, see Can Eating More Mushrooms Extend Your Lifespan? Ergothioneine Evidence.

How Ergothioneine May Protect the Aging Brain: The Cellular Mechanism

The observational data is consistent, but a hypothesis needs a plausible biological mechanism to be taken seriously. Three lines of preclinical evidence are relevant here.

First, Apparoo and colleagues published 2024 animal research demonstrating that ergothioneine from mushrooms can clear senescent cells from neurons.^[7] Senescent cells are sometimes called "zombie cells" because they stop dividing but do not die, instead releasing inflammatory signals that damage surrounding tissue. In the aging brain, accumulation of senescent neurons is associated with cognitive decline. Apparoo's study provides a specific mechanism through which ergothioneine could slow brain aging at the cellular level, independent of its antioxidant function.

Second, Lam-Sidun and colleagues synthesized preclinical evidence showing ergothioneine protects against cellular damage from excess dietary fats, oxidative stress, and inflammatory signaling, the same processes that underlie the cardiovascular and metabolic diseases accelerated aging produces.^[8] These are the hallmarks that Blue Zone research repeatedly identifies as lower in long-lived populations.

Third, Cheah and Halliwell's 2021 review provides the broadest mechanistic synthesis: ergothioneine accumulates in mitochondria-rich tissues, protects against oxidative and inflammatory damage that drives cellular aging, and maintains this protective role across multiple tissue types.^[3]

Together, these three mechanisms (senescent cell clearance, cardiovascular and metabolic protection, and mitochondrial antioxidant defense) give ergothioneine a biologically coherent story for why dietary adequacy would matter for long-term health outcomes.

The Important Caveat: Blue Zone Longevity Is Multifactorial and Contested

The dietary patterns that characterize Blue Zones are complex and co-vary heavily. Okinawans who eat more mushrooms also eat more fermented foods, more fish, less meat, and live in social structures with strong community bonds. They typically have lower smoking rates and more physical activity than the U.S. comparison population. Attributing their longevity to any single dietary component, including ergothioneine, requires isolating that compound from everything else in their lives.

The Hisayama Study is the best available evidence precisely because it attempts to do this: it measures serum ergothioneine in Japanese adults and tests whether that biomarker predicts outcomes independently of other risk factors. The adjustment for confounders in Meng et al. is a serious attempt to isolate the ergothioneine signal. But observational adjustment is never perfect. Residual confounding is always possible.

The honest characterization is: ergothioneine is a compelling, testable candidate mechanism connecting Blue Zone dietary patterns to longevity outcomes. The data supporting it is more substantial than most dietary longevity claims. It is not proven.

Which Mushrooms Deliver Blue Zone Ergothioneine Levels?

The traditional Okinawan mushrooms, shiitake, enoki, and maitake, are all meaningful ergothioneine sources. Shiitake is the most commercially accessible in Western markets and the most commonly studied for ergothioneine content. Maitake and enoki appear regularly in Japanese soups and hot pots, preparation methods that preserve rather than destroy the compound. Dried forms of any mushroom concentrate ergothioneine further, which may partially explain why dried shiitake has such a prominent role in traditional Japanese cooking.

For a full species-by-species comparison of ergothioneine concentrations across common and specialty mushroom varieties, see Ergothioneine Content by Mushroom Species: A Complete Ranking.

For the Nagano Prefecture longevity connection, where enoki specifically has been studied in elderly populations, see Enoki and Memory in Aging Populations: Nagano Longevity Study Insights.

The Bottom Line

The ergothioneine-Blue Zones dietary connection rests on three converging lines of evidence: Blue Zone populations, especially in Okinawa, have traditional high mushroom consumption; ergothioneine is the only dietary compound that comes almost exclusively from fungi, making mushroom-heavy diets the only path to high dietary ergothioneine; and the 2025 Hisayama Study, conducted in Japan, a high-mushroom-consumption country, found significantly lower dementia risk in the 1,344 participants with higher serum ergothioneine over 11.2 years. The hypothesis is testable and growing in evidence base, but Blue Zone longevity is multifactorial and ergothioneine remains one proposed mechanism among many.

Frequently Asked Questions

Do people in blue zones eat a lot of mushrooms?

Okinawa, Japan's most studied Blue Zone, has traditional high mushroom consumption: shiitake, enoki, maitake, and wood ear mushrooms appear frequently in traditional Okinawan cooking. Sardinian and Icarian diets also incorporate local and foraged mushrooms, though less systematically documented. Mushrooms appear in most Blue Zone dietary analyses but are rarely foregrounded in comparison to legumes or fish.

Is ergothioneine the reason mushroom eaters live longer?

Ergothioneine is proposed as one mechanism, not the only reason. Ba et al. (2021) found lower all-cause mortality in U.S. mushroom consumers in two independent NHANES analyses. Meng et al. (2025) found lower dementia risk in Japanese adults with higher serum ergothioneine over 11.2 years. These associations are consistent across populations, but mushroom consumption correlates with other healthy behaviors, and no human RCT has tested ergothioneine supplementation for longevity outcomes.

What is the connection between the Okinawa diet and longevity?

Okinawan longevity is attributed to multiple factors: low caloric intake (hara hachi bu, the practice of eating to 80% full), high vegetable and legume consumption, regular fish, strong social bonds, and low chronic stress. Mushrooms are part of the traditional diet. Researchers have proposed that ergothioneine from regular mushroom consumption may be one underappreciated dietary contributor, supported by the 2025 Hisayama Study in a Japanese elderly population showing higher ergothioneine predicting lower dementia risk over 11.2 years.

Which mushrooms have the most longevity benefits?

Ergothioneine content varies considerably by species, and the research points to meaningful differences across common varieties. Shiitake, maitake, and enoki, the mushrooms most common in traditional Okinawan cooking, are all solid contributors and have been specifically identified in dietary pattern analyses of high-longevity Japanese populations. Dried mushrooms concentrate ergothioneine compared to their fresh equivalents. For a complete species-by-species ranking based on measured ergothioneine content, see the dedicated guide to ergothioneine content by mushroom species.

Is the blue zone diet high in ergothioneine?

By comparison to U.S. diets (estimated at 1.1 mg/day), yes. Okinawan, Sardinian, and Icarian diets with regular mushroom consumption would supply substantially more ergothioneine. No published study has directly measured dietary ergothioneine intake in a Blue Zone population, but the species consumed and frequency of consumption in places like Okinawa suggest intakes well above the U.S. average. The Hisayama Study's Japanese elderly cohort provides the best proxy: a population with traditional mushroom consumption showed a significant ergothioneine-dementia protection signal over 11.2 years.

Sources & References

1. 1RTHM-02144·Meng, Xiangyin et al. (2025). “Serum ergothioneine and risk of dementia in a general older Japanese population: the Hisayama Study..” Psychiatry and clinical neurosciences.Study breakdown →PubMed →↩
2. 2RTHM-01170·Beelman, Robert B et al. (2020). “Is ergothioneine a 'longevity vitamin' limited in the American diet?.” Journal of nutritional science.Study breakdown →PubMed →↩
3. 3RTHM-00678·Cheah, Irwin K et al. (2021). “Ergothioneine, recent developments..” Redox biology.Study breakdown →PubMed →↩
4. 4RTHM-00655·Smith, Einar et al. (2020). “Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease..” Heart (British Cardiac Society).Study breakdown →PubMed →↩
5. 5RTHM-00673·Ba, Djibril M et al. (2021). “Association of mushroom consumption with all-cause and cause-specific mortality among American adults: prospective cohort study findings from NHANES III..” Nutrition journal.Study breakdown →PubMed →↩
6. 6RTHM-00674·Ba, Djibril M et al. (2021). “Prospective study of dietary mushroom intake and risk of mortality: results from continuous National Health and Nutrition Examination Survey (NHANES) 2003-2014 and a meta-analysis..” Nutrition journal.Study breakdown →PubMed →↩
7. 7RTHM-01850·Apparoo, Yasaaswini et al. (2024). “Potential role of ergothioneine rich mushroom as anti-aging candidate through elimination of neuronal senescent cells..” Brain research.Study breakdown →PubMed →↩
8. 8RTHM-00696·Lam-Sidun, Daniel et al. (2021). “Mushroom-Derived Medicine? Preclinical Studies Suggest Potential Benefits of Ergothioneine for Cardiometabolic Health..” International journal of molecular sciences.Study breakdown →PubMed →↩